| AMINO
ACIDS ADVANCED INTERMEDIATES |
|
Piperidinyl Amino Acids
Combines the structural characteristics of isonipecotic acid,
nipecotic acid, 2,4-diaminobutyric acid (DABA), and
3-aminocyclohexanecarboxylic acid (ACHC). Nipecotic acid, DABA,
and ACHC are substrate-competitive inhibitors of the neuronal
GABA uptake system.
(1) Jacobsen, P. et al; Potential GABA
Uptake Inhibitors. Synthesis and Relative Stereochemistry of
Some Aminopiperidine Carboxylic Acids; Acta Chemica
Scandinavica B 1980, 34, 319-326.
(2) Bagley, J. R. et al; New
1-(Heterocyclylalkyl)-4-(Propionanilido)-4-Piperidinyl Methyl
Ester and Methylene Methyl Ether Analgesics; Journal of
Medicinal Chemistry 1991, 34, 827-841.
(3) Heimgartner, H. et al; Novel Heterospirocyclic
3-Amino-2H-azirines as Synthons for Heterocyclic a-Amino
Acids; Helvetica Chimica Acta 1997, 80, 1528-1554.
|
| Name |
Reference |
N-Boc-amino-(4-N-Boc-piperidinyl)
carboxylic acid
[189321-65-1] |
36045 |
4-N-Boc-1,1-amino-piperidinyl
carboxylic acid
[183673-71-4] |
36038 |
N-Fmoc-amino-(3-N-Boc-piperidinyl)
carboxylic acid
[189321-65-1] |
36051 |
N-Fmoc-amino-(4-N-Boc-piperidinyl)carboxylic
acid
[183673-66-7] |
36037 |
|
[ back
to products list ]
|
|
Tetrahydropyran and tetra-hydrothiopyranyl
amino acids
Tetrahydropyran and tetrahydrothiopyranyl amino acids are
potential inhibitors of the enzyme S-adenosylmethionine (AdoMet)
synthetase.
S-adenosylmethionine synthetase catalyses the reaction of ATP
and L-methionine to yield S-adenosylmethionine (AdoMet),
pyrophospate, and orthophosphate. AdoMet is utilized by
methyltransferases for the methylation of RNA, DNA, histones,
proteins, polysaccarides, steroids, and numerous other
metabolites. The rational design of methylation inhibitors
based on the inhibition of enzymes involved in AdoMet
metabolism has attracted the attention of medicinal chemists
in the search for antitumor and antiviral agents.
Guillerm, G.et al,; A New Series of Cyclic
Amino Acids as Inhibitors of S-Adenosyl L-Methionine
Synthetase; Bioorganic & Medicinal Chemistry Letters 1998,
8, 1629-1634.
|
| Name |
Reference |
4-Amino-4-carboxytetrahydropyran
hydrochloride
[217299-03-1] |
36041 |
4-Amino-4-carboxytetrahydrothiopyran
hydrochloride
[67639-41-2] |
36050 |
| 4-N-Boc-amino-4-carboxy-1,1-dioxo-tetrahydrothiopyran |
36052 |
4-N-Boc-amino-4-carboxytetrahydropyran
[172843-97-9] |
36046 |
4-N-Boc-amino-4-carboxytetrahydrothiopyran
[108329-81-3] |
36040 |
|
4-N-Fmoc-amino-4-carboxytetrahydrothiopyran
|
36049 |
| N-Fmoc-amino-4-(ethylene
ketal) cyclohexylcarboxylic acid |
36039 |
[ back
to products list ]
|
|
2-Amino-3-piperidin-4-yl propionic
acids
2-Amino-3-piperidin-4-yl propionic acids serve as building
blocks for piperidinyl-containing protease inhibitors. Adang
et al demonstrated (1) the use of 2-amino-3-piperidin-4-yl
propionic acid as a component of a new and efficient P1
isostere in the serine protease area.
(1) Adang, A.E. P. et al; Solution-phase
and Solid-phase Synthesis of Novel Transition State Inhibitors
of Coagulation Enzymes Incorporating a Piperidinyl Moiety;
Bioorganic & Medicinal Chemistry Letters 1999, 9,
1227-1232.
|
| Name |
Reference |
2-N-Boc-amino-3-(4-tetrahydropyranyl)propionic
acid
[182287-51-0] |
36048 |
| 2-N-Boc-amino-3-(4-tetrahydrothiopyranyl)propionic
acid |
36047 |
2-N-Fmoc-amino-3-(4-N-Boc-piperidinyl)propionic
acid
[313052-02-7] |
36043 |
[ back
to products list ]
|
|
3-Amino-3-arylpropionic acids
3-Amino-3-arylpropionic acids have found therapeutic
application in the fields of neuroscience, oncology (1), and
virology.
(1) Guillon, J. et al; Synthesis of New
Ethyl-3-[3-N’-(2-chloroethyl)-3-N’-nitrosoureido]-3-aryl-propionates
as Potential Anticancer Agents; Pharm. Pharmacol. Commun.1998,
4, 231-235.
|
| Name |
Reference |
| 3-Amino-3-(3-t-butoxyphenyl)propionic
acid |
36044 |
3-N-Boc-amino-3-(4-chlorophenyl)propionic
acid
[284493-65-8] |
36042 |
[ back
to products list ]
|
| CHIRAL
BUILDING BLOCKS, SCAFFOLDS, AND ADVANCED INTERMEDIATES |
Scaffolds
Functionalised Cyclopentanes |
| Name |
Reference |
(1R,2S,4S)-N-Boc-1-amino-2-hydroxycyclopentane-4-carboxylic
acid methyl ester
C12H21NO5
[321744-14-3] |
36229 |
(1S,2R,4R)-N-Boc-1-amino-2-hydroxycyclopentane-4-carboxylic
acid methyl ester
C12H21NO5
[321744-23-4] |
36230 |
(1R,2R,4S)-N-Boc-1-amino-2-hydroxycyclopentane-4-carboxylic
acid methyl ester
C12H21NO5
[321744-16-5] |
36231 |
(1S,2S,4R)-N-Boc-1-amino-2-hydroxycyclopentane-4-carboxylic
acid methyl ester
C12H21NO5
[262280-14-8] |
36232 |
|
(1R,2S,4R)-N-Boc-1-amino-2-hydroxycyclopentane-4-carboxylic
acid methyl ester
C12H21NO5
[321744-17-6]
Manufactured under EP 0 592 552 B1 and
US 5,532,395
|
36233 |
(1S,2R,4S)-N-Boc-1-amino-2-hydroxycyclopentane-4-carboxylic
acid methyl ester
C12H21NO5
[321744-21-2]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36234 |
(1R,2R,4R)-N-Boc-1-amino-2-hydroxycyclopentane-4-carboxylic
acid methyl ester
C12H21NO5
[321744-18-7]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36235 |
(1S,2S,4S)-N-Boc-1-amino-2-hydroxycyclopentane-4-carboxylic
acid methyl ester
C12H21NO5
[321744-19-8]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36236 |
[ back
to products list ]
|
Scaffolds
Functionalised Piperidines |
| Name |
Reference |
(2S,4R)-N-Boc-4-hydroxy
piperidine-2-carboxylic acid methyl ester
C12H21NO5 |
36200 |
(2R,4S)-N-Boc-4-hydroxypiperidine-2-carboxylic
acid methyl ester
C12H21NO5
[321744-26-7] |
36297 |
(2S,4S)-N-Boc-4-hydroxy
piperidine-2-carboxylic acid benzylamine salt
C18H28N2O5 |
36201 |
[ back
to products list ]
|
Building
Blocks and Advanced Intermediates
Functionalised Cyclopentanes |
| Name |
Reference |
(1R,4S)-2-Aza-bicyclo[2.2.1]hept-5-en-3-one
C6H7NO
[79200-56-9] |
29704 |
(1S,4R)-2-Aza-bicyclo[2.2.1]hept-5-en-3-one
C6H7NO
[130931-83-8] |
29705 |
(1R,2S,3R,4R)-2,3-Dihydroxy-4-(hydroxymethyl)-1-aminocyclopentane
hydrochloride
C6H14ClNO3
[79200-57-0] |
36252 |
(1S,2R,3S,4S)-2,3-dihydroxy-4-(hydroxymethyl)-1-aminocyclopentane
hydrochloride
C6H14ClNO3
[220497-88-1] |
36253 |
(1S,2R,6S,7R)-4,4-Dimethyl-3,5-dioxa-8-aza-tricyclo[5.2.1.02,6]decan-9-one
C9H13NO3
[178032-63-8] |
36220 |
(1R,2S,6R,7S)-4,4-Dimethyl-3,5-dioxa-8-aza-tricyclo[5.2.1.02,6]decan-9-one
C9H13NO3
[220507-10-8] |
36221 |
(1S,4R)-2-Aza-bicyclo[2.2.1]heptan-3-one
C6H9NO
[134003-03-5] |
36222 |
(1S,3R,4S,6R)-N-Boc-6-amino-2,2-dimethyl-tetrahydro-cyclopenta[1.3]dioxole-4-carboxylic
acid
C14H23NO6
[220497-93-8] |
36223 |
(1R,3S,4R,6S)-N-Boc-6-amino-2,2-dimethyl-tetrahydro-cyclopenta[1.3]dioxole-4-carboxylic
acid
C14H23NO6
[220497-94-9] |
36224 |
(1S,4R)-4-Amino-cyclopent-2-ene
carboxylic acid
C6H9NO2
[102579-72-6] |
36225 |
(1R,4S)-4-Amino-cyclopent-2-ene
carboxylic acid
C6H9NO2
[134003-04-6] |
36226 |
(1R,3S)-3-Amino-cyclopentane
carboxylic acid
C6H11NO2
[71830-08-5] |
36227 |
|
(1S,3R)-3-Amino-cyclopentane carboxylic acid
C6H11NO2
[71830-07-4]
|
36228 |
(R)-4-tert-Butyldimethylsilyloxy-2-cyclopenten-1-one
C11H20O2Si
[61305-35-9] |
36237 |
(S)-4-tert-Butyldimethylsilyloxy-2-cyclopenten-1-one
C11H20O2Si
[61305-36-0] |
36238 |
(1R,3R)-N-Boc-3-aminocyclopentane
carboxylic acid
C11H19NO4 |
36239 |
(1S,3S)-N-Boc-1-aminocyclopentane-3-carboxylic
acid methyl ester
C12H21NO4
[329910-39-6] |
36240 |
[ back
to products list ]
|
Building
Blocks and Advanced Intermediates
2-Alkyl Succinates |
| Name |
Reference |
(R)-2-Isopropylsuccinic
acid 1-methyl ester
C8H14O4
[220498-08-8]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36306 |
(S)-2-Isopropylsuccinic
acid 1-methyl ester
C8H14O4
[208113-95-5]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36211 |
(R)-2-Butylsuccinic acid
1-methyl ester
C9H16O4
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36308 |
(R)-2-Isobutylsuccinic
acid 1-methyl ester
C9H16O4
[130165-76-3]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36305 |
(S)-2-Isobutylsuccinic
acid 1-methyl ester
C9H16O4
[213270-36-1]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36210 |
(R)-2-Cyclohexylsuccinic
acid 1-methyl ester
C11H18O4
[220498-07-7]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36304 |
(S)-2-Cyclohexylsuccinic
acid 1-methyl ester
C11H18O4
[213270-44-1]
Manufactured using DuPont technology
under patent EP 0 592 552 B1 |
36209 |
(R)-2-Benzylsuccinic acid
1-methyl ester
C12H14O4
[119807-84-0]
Manufactured using DuPont technology
under patent EP 0 592 552 B1 |
36302 |
(S)-2-Benzylsuccinic acid
1-methyl ester
C12H14O4
[182247-45-6]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36207 |
(R)-2-(Cyclohexylmethyl)succinic
acid 1-methyl ester
C12H20O4
[130165-88-7]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36303 |
(S)-2-(Cyclohexylmethyl)succinic
acid 1-methyl ester
C12H20O4
[220497-69-8]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36208 |
(R)-2-(2-Naphthyl)succinic
acid 1-methyl ester
C16H16O4
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36307 |
(S)-2-(2-Naphthylmethyl)succinic
acid 1-methyl ester
C16H16O4
[220497-75-6]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36213 |
(S)-2-(1-Naphthylmethyl)succinic
acid 1-methyl ester
C16H16O4
[130693-96-8]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36212 |
[ back
to products list ]
|
Building
Blocks and Advanced Intermediates
Alcohols |
| Name |
Reference |
(S)-3-Butyn-2-ol
C4H6O
[2914-69-4] |
36241 |
(R)-(+)-endo-Norborneol
C7H12O
[36779-79-0] |
36315 |
(S)-1-Octyn-3-ol
C8H14O
[32556-71-1] |
36243 |
(R)-1-Octyn-3-ol
C8H14O
[32556-70-0] |
36317 |
[ back
to products list ]
|
Building
Blocks and Advanced Intermediates
Amines |
| Name |
Reference |
(S)-Cyclohex-2-enylamine
C6H11N
[153922-89-5]
Manufactured under US patent 5,739,396 |
36218 |
(R)-2-Aminoheptane
C7H17N
[6240-90-0] |
36309 |
(S)-2-Aminoheptane
C7H17N
[44745-29-1] |
36214 |
(R)-1-(4-Bromophenyl)
ethylamine
C8H10BrN
[45791-36-4] |
36313 |
(R)-2-Amino-6-methylheptane
C8H19N
[70419-11-3] |
36310 |
(S)-2-Amino-6-methylheptane
C8H19N
[70419-10-2] |
36215 |
(R)-2-Amino octane
C8H19N
[34566-05-7] |
36311 |
(S)-2-Aminooctane
C8H19N
[34566-04-6] |
36216 |
[ back
to products list ]
|
Building
Blocks and Advanced Intermediates
Amino Acids |
| Name |
Reference |
(R)-4-Fluorophenylglycine
C8H8FNO2
[93939-74-3] |
36301 |
(S)-4-Fluorophenylglycine
C8H8FNO2
[19883-57-9] |
36205 |
(S)-N-3-Cyanophenylalanine
C10H10N2O2
[57213-48-6] |
36206 |
(R)-3-Amino-3-phenylpropanoic
acid ethyl ester hydrochloride salt
C11H16ClNO2
[340188-50-3] |
36299 |
(S)-3-Amino-3-phenylpropanoic
acid ethyl ester hydrochloride salt
C12H15NO2Cl
[167834-24-4] |
36204 |
(R)-N-Acetyl-2-naphthylalanine
C15H15NO3
[37440-01-0]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36300 |
[ back
to products list ]
|
Building
Blocks and Advanced Intermediates
Boc Amino Acids |
| Name |
Reference |
|
(S)-N-Boc-azetidine carboxylic acid
C9H15NO4
[51077-14-6]
|
36190 |
|
(R)-N-Boc-propargylglycine
C10H15NO4
[63039-46-3]
|
36285 |
|
(S)-N-Boc-propargylglycine
C10H15NO4
[63039-48-5]
|
36180 |
|
(R)-N-Boc-allylglycine
C10H17NO4
[170899-08-8]
|
36284 |
|
(S)-N-Boc-allylglycine
C10H17NO4
[170899-08-8]
|
36179 |
|
(S)-N-Boc-4-thiazoylalanine
C11H16N2O4S
[119434-75-2]
|
36178 |
|
(1R,4S)-N-Boc-1-aminocyclopent-2-ene-4-carboxylic acid
C11H17NO4
[151907-79-8]
|
36181 |
|
(1S,4R)-N-Boc-1-aminocyclopent-2-ene-4-carboxylic acid
C11H17NO4
[108999-93-5]
|
36182 |
|
(1R,3S)-N-Boc-1-aminocyclopentane-3-carboxylic acid
C11H19NO4
[261165-05-3]
|
36183 |
|
(1S,3R)-N-Boc-1-aminocyclopentane-3-carboxylic acid
C11H19NO4
[161660-94-2]
|
36184 |
|
(R)-N-Boc-2-(5-bromothienyl)alanine
C12H16BrNO4S
[261380-16-9]
Manufactured under EP 0 592 552 B1 and
US 5,532,395
|
36277 |
|
(S)-N-Boc-2-(5-bromothienyl)-alanine
C12H16BrNO4S
[190319-95-0]
Manufactured under EP 0 592 552 B1 and
US 5,532,395
|
36170 |
|
(R)-N-Boc-2-thienylalanine
C12H17NO4S
[78452-55-8]
Manufactured under EP 0 592 552 B1 and
US 5,532,395
|
36282 |
|
(S)-N-Boc-2-thienylalanine
C12H17NO4S
[56675-37-7]
Manufactured under EP 0 592 552 B1 and
US 5,532,395
|
36176 |
|
(R)-N-Boc-3-thienylalanine
C12H17NO4S
[226880-86-0]
Manufactured under EP 0 592 552 B1 and
5,532,395
|
36283 |
|
(S)-N-Boc-3-thienylalanine
C12H17NO4S
[56675-37-7]
Manufactured under EP 0 592 552 B1 and
US 5,532,395
|
36177 |
|
(R)-N-Boc-2-furylalanine
C12H17NO5
[261380-18-1]
Manufactured under EP 0 592 552 B1 and
US 5,532,395
|
36279 |
|
(S)-N-Boc-2-furylalanine
C12H17NO5
[145206-40-2]
Manufactured under EP 0 592 552 B1 and
US 5,532,395
|
36172 |
|
(R)-N-Boc-3-pyridylalanine
C13H18N2O4
[98266-33-2]
Manufactured under EP 0 592 552 B1 and
US 5,532,395
|
36293 |
|
(S)-N-Boc-3-pyridylalanine
C13H18N2O4
[117142-26-4]
Manufactured under EP 0 592 552 B1 and
US 5,532,395
|
36195 |
|
(S)-N-Boc-(2-pyridyl)alanine
C13H18N2O4
[71239-85-5]
|
36174 |
|
(R)-N-Boc-4-pyridylalanine
C13H18N2O4
[37535-58-3]
Manufactured under EP 0 592 552 B1 and
US 5,532,395
|
36296 |
|
(S)-N-Boc-4-pyridylalanine
C13H18N2O4
[37535-57-2]
Manufactured under EP 0 592 552 B1 and
US 5,532,395
|
36199 |
|
(R)-N-Boc-3,4-dichlorophenylalanine
C14H17Cl2NO4
[114873-13-1]
Manufactured under EP 0 592 552 B1 and
US 5,532,395
|
36294 |
|
(S)-N-Boc-3,4-dichlorophenylalanine
C14H17Cl2NO4
[80741-39-5]
Manufactured under EP 0 592 552 B1 and
US 5,532,395
|
36196 |
|
(R)-N-Boc-3-amino-3-(4-bromophenyl)propanoic acid
C14H18BrNO4
[261380-20-5]
|
36287 |
|
(S)-N-Boc-3-amino-3-(4-bromophenyl)propanoic acid
C14H18BrNO4
[261165-06-4]
|
36186 |
|
(R)-N-Boc-2-bromophenylalanine
C14H18BrNO4
[261360-76-3]
Manufactured under EP 0 592 552 B1 and
US 5,532,395
|
36274 |
(S)-N-Boc-2-bromophenylalanine
C14H18BrNO4
[261165-02-0]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36167 |
(R)-N-Boc-3-bromophenylalanine
C14H18BrNO4
[261360-77-4]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36275 |
(S)-N-Boc-3-bromophenylalanine
C14H18BrNO4
[82278-73-7]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36168 |
(R)-N-Boc-4-bromophenylalanine
C14H18BrNO4
[79561-82-3]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36276 |
(S)-N-Boc-4-bromophenylalanine
C14H18BrNO4
[62129-39-9]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36169 |
(R)-N-Boc-4-chlorophenylalanine
C14H18ClNO4
[57292-44-1
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36292 |
(S)-N-Boc-4-chlorophenylalanine
C14H18ClNO4
[68090-88-0]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36194 |
(S)-N-Boc-3-fluorophenylalanine
C14H18FNO4
[114873-01-7]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36187 |
(S)-N-Boc-4-fluorophenylalanine
C14H18FNO4
[41153-30-4]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36188 |
(R)-N-Boc-2-fluorophenylalanine
C14H18FNO4
[114873-10-8]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36290 |
(S)-N-Boc-2-fluorophenylalanine
C14H18FNO4
[114873-00-6]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36191 |
(R)-N-Boc-3-fluorophenylalanine
C14H18FNO4
[114873-11-9]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36288 |
(R)-N-Boc-4-fluorophenylalanine
C14H18FNO4
[57292-45-2]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36443 |
(R)-N-Boc-4-fluorophenylglycine
C14H18FNO4
[196707-32-1] |
36291 |
(S)-N-Boc-4-fluorophenylglycine
C14H18FNO4
[142186-36-5] |
36192 |
(R)-N-Boc-3-amino-3-phenylpropanoic
acid
C14H19NO4
[161024-80-2] |
36286 |
(S)-N-Boc-3-amino-3-phenylpropanoic
acid
C14H19NO4
[103365-47-5] |
36185 |
(R)-N-Boc-4-cyanophenylalanine
C15H18N2O4
[146727-62-0]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36289 |
(S)-N-Boc-4-cyanophenylalanine
C15H18N2O4
[131724-45-3]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36189 |
(S)-N-Boc-3-cyanophenylalanine
C15H18N2O4
[131980-30-8] |
36193 |
(R)-N-Boc-(5-bromo-2-methoxyphenyl)alanine
C15H20BrNO5
[261380-17-0]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36278 |
(S)-N-Boc-(5-bromo-2-methoxyphenyl)alanine
C15H20BrNO5
[261165-03-1]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36171 |
(2S,3R)-N-Boc-2-amino-3-phenylbutyric
acid
C15H21NO4
[145432-51-5] |
36203 |
(R)-N-Boc-styrylalanine
C16H21NO4
[261380-19-2]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36281 |
(S)-N-Boc-styrylalanine
C16H21NO4
[261165-04-2]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36175 |
(R)-N-Boc-2-naphthylalanine
C18H21NO4
[76985-10-9]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36280 |
(S)-N-Boc-2-naphthylalanine
C18H21NO4
[58438-04-3]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36173 |
(R)-N-Boc-1-naphthylalanine
C18H21NO4
[76932-48-4]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36295 |
(S)-N-Boc-1-naphthylalanine
C18H21NO4
[55447-00-2]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36198 |
[ back
to products list ]
|
Building
Blocks and Advanced Intermediates
Fmoc Amino Acids |
| Name |
Reference |
(R)-N-Fmoc-azetidine-2-carboxylic
acid
C19H17NO4 |
36268 |
(S)-N-Fmoc-azetidine-2-carboxylic
acid
C19H17NO4
[136552-06-2] |
36160 |
(R)-N-Fmoc-propargylglycine
C20H17NO4 |
36262 |
(S)-N-Fmoc-propargylglycine
C20H17NO4
[198561-07-8] |
36150 |
(R)-N-Fmoc-(2-bromoallyl)glycine
C20H18BrNO4
[220497-92-7] |
36260 |
(S)-N-Fmoc-(2-bromoallyl)-glycine
C20H18BrNO4
[220497-60-9] |
36147 |
(R)-N-Fmoc-allylglycine
C20H19NO4
[170642-28-1] |
36259 |
(S)-N-Fmoc-allylglycine
C20H19NO4
[146549-21-5] |
36146 |
(R)-N-Fmoc-4-thiazoylalanine
C21H18N2O4S
[205528-33-2] |
36258 |
(S)-N-Fmoc-4-thiazoylalanine
C21H18N2O4S
[205528-32-1] |
36145 |
(1R,4S)-N-Fmoc-1-aminocyclopent-2-ene-4-carboxylic
acid
C21H19NO4
[220497-65-4] |
36151 |
(1S,4R)-N-Fmoc-1-aminocyclopent-2-ene-4-carboxylic
acid
C21H19NO4
[220497-64-3] |
36152 |
(1R,3S)-N-Fmoc-1-aminocyclopentane-3-carboxylic
acid
C21H21NO4
[220497-66-5] |
36153 |
(1S,3R)-N-Fmoc-1-aminocyclopentane-3-carboxylic
acid
C21H21NO4
[220497-67-6] |
36154 |
(R)-N-Fmoc-2-(5-bromothienyl)alanine
C22H18BrNO4S
[220497-83-6]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36248 |
(S)-N-Fmoc-2-(5-bromothienyl)-alanine
C22H18BrNO4S
[220497-50-7]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36138 |
(R)-N-Fmoc-2-thienylalanine
C22H19NO4S
[201532-42-5]
Manufactured under P 0 592 552 B1 and
US 5,532,395 |
36256 |
(S)-N-Fmoc-2-thienylalanine
C22H19NO4S
[130309-35-2]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36143 |
(R)-N-Fmoc-3-thienylalanine
C22H19NO4S
[220497-90-5]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36257 |
(S)-N-Fmoc-3-thienylalanine
C22H19NO4S
[186320-06-9]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36144 |
(R)-N-Fmoc-(2-furyl)alanine
C22H19NO5
[220497-85-8]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36249 |
(S)-N-Fmoc-(2-furyl)alanine
C22H19NO5
[159611-02-6]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36139 |
(R)-N-Fmoc-4-fluorophenylglycine
C23H18FNO4 |
36270 |
(S)-N-Fmoc-4-fluorophenylglycine
C23H18FNO4 |
36161 |
(R)-N-Fmoc-3-pyridylalanine
C23H20N2O4
[142994-45-4]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36273 |
(R)-N-Fmoc-(2-pyridyl)-alanine
C23H20N2O4
[185379-39-9] |
36254 |
(S)-N-Fmoc-(2-pyridyl)-alanine
C23H20N2O4
[185379-40-2] |
36141 |
(S)-N-Fmoc-3-pyridylalanine
C23H20N2O4
[175453-07-3]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36164 |
(R)-N-Fmoc-3-amino-3-(4-bromophenyl)propanoic
acid
C24H20BrNO4
[220498-04-4] |
36264 |
(S)-N-Fmoc-3-amino-3-(4-bromophenyl)propanoic
acid
C24H20BrNO4
[220497-68-7] |
36156 |
(R)-N-Fmoc-2-bromophenylalanine
C24H20BrNO4
[220497-79-0]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36245 |
(S)-N-Fmoc-2-bromophenylalanine
C24H20BrNO4
[220497-47-2]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36134 |
(R)-N-Fmoc-3-bromophenylalanine
C24H20BrNO4
[220497-81-4]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36246 |
(S)-N-Fmoc-3-bromophenylalanine
C24H20BrNO4
[220497-48-3]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36136 |
(R)-N-Fmoc-4-bromophenylalanine
C24H20BrNO4
[198545-76-5]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36247 |
(S)-N-Fmoc-4-bromophenylalanine
C24H20BrNO4
[198561-04-5]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36137 |
(R)-N-Fmoc-4-chlorophenylalanine
C24H20ClNO4
[142994-19-2]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36272 |
(S)-N-Fmoc-4-chlorophenylalanine
C24H20ClNO4
[175453-08-4]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36163 |
(R)-N-Fmoc-2-fluorophenylalanine
C24H20FNO4
[198545-46-9]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36269 |
(S)-N-Fmoc-2-fluorophenylalanine
C24H20FNO4
[205526-26-7]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36251 |
(R)-N-Fmoc-3-fluorophenylalanine
C24H20FNO4
[198545-72-1]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36265 |
(S)-N-Fmoc-3-fluorophenylalanine
C24H20FNO4
[198560-68-8]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36157 |
(R)-N-Fmoc-4-fluorophenylalanine
C24H20FNO4
[177966-64-2]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36266 |
(S)-N-Fmoc-4-fluorophenylalanine
C24H20FNO4
[169243-86-1]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36158 |
(S)-N-Fmoc-3-amino-3-(3-nitrophenyl)propanoic
acid
C24H20N2O6
[206060-42-6] |
36165 |
(R)-N-Fmoc-3-amino-3-phenylpropanoic
acid
C24H21NO4
[220498-02-2] |
36263 |
(S)-N-Fmoc-3-amino-3-phenylpropanoic
acid
C24H21NO4
[209252-15-3] |
36155 |
(S)-N-Fmoc-2-amino-2-cyclohexyl-propanoic
acid
C24H27NO4
[135673-97-1]
Manufactured under US patent 5,739,396 |
36148 |
(R)-N-Fmoc-3-cyanophenylalanine
C25H20N2O4
[205526-37-0] |
36271 |
(S)-N-Fmoc-3-cyanophenylalanine
C25H20N2O4
[205526-36-9] |
36162 |
(R)-N-Fmoc-4-cyanophenylalanine
C25H20N2O4
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36267 |
(S)-N-Fmoc-4-cyanophenylalanine
C25H20N2O4
[173963-93-4]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36159 |
(R)-N-Fmoc-octylglycine
C25H31NO4
[220497-96-1] |
36261 |
(S)-N-Fmoc-octylglycine
C25H31NO4
[193885-59-5] |
36149 |
(R)-N-Fmoc-styrylalanine
C26H23NO4
[215190-23-1]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36255 |
(S)-N-Fmoc-styrylalanine
C26H23NO4
[159610-82-9]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36142 |
(S)-N-Fmoc-1-naphthylalanine
C28H23NO4
[96402-49-2]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36166 |
(R)-N-Fmoc-2-naphthylalanine
C28H23NO4
[138774-94-4]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36250 |
(S)-N-Fmoc-2-naphthylalanine
C28H23NO4
[112883-43-9]
Manufactured under EP 0 592 552 B1 and
US 5,532,395 |
36140 |
[ back
to products list ]
|
Building
Blocks and Advanced Intermediates
Amino Alcohols |
| Name |
Reference |
(R)-3-Amino-3-phenylpropan-1-ol
C9H13NO
[170564-98-4] |
36312 |
(S)-3-Amino-3-phenyl
propan-1-ol
C9H13NO
[82769-76-4] |
36217 |
(R)-2-Aminobut-3-en-1-ol ,
benzoate salt
C11H15NO3
Manufactured under US patent 5,739,396 |
36316 |
(S)-2-Aminobut-3-en-1-ol,
benzoate salt
C11H15NO3
[261360-75-2]
Manufactured under US patent 5,739,396 |
36242 |
(R)-N-Phthaloyl-2-aminobut-3-en-1-ol
C12H11NO3
[174810-06-1]
Manufactured under US patent 5,739,396 |
36318 |
[ back
to products list ]
|
Building
Blocks and Advanced Intermediates
Diols |
| Name |
Reference |
(2R,5R)-2,5-hexanediol
C6H14O2
[17299-07-9] |
36320 |
(3R,6R)-3,6-octanediol
C8H18O2
[129619-37-0] |
36321 |
(3S,6S)-3,6-octanediol
C8H18O2
[136705-66-3] |
36322 |
[ back
to products list ]
|
Building
Blocks and Advanced Intermediates
Halo Acids |
| Name |
Reference |
(R)-5-Phthalimido-2-bromovaleric
acid
C13H12BrNO4
[179090-36-9] |
36319 |